Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
ACELYRIN $621 million IPO
The stock is listed on the Nasdaq Global Select Market
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
Ocado Group acquisition of 6 River Systems
We are advising Ocado Group on the transaction
Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
We are advising Cellular Biomedicine Group on the transaction
Crestview strategic investment in The Gersh Agency
We advised Crestview Partners on the transaction
Virgin Orbit chapter 11 filing and DIP financing
We are advising Virgin Investments in connection with the restructuring and as DIP lender
Emerson $8.2 billion acquisition of National Instruments
We are advising Emerson on the transaction
TPG acquisition of majority stake in Thomson Reuters’ Elite business
We are advising TPG on the transaction
Natura $2.525 billion sale of Aesop to L’Oréal
We are advising Natura on the transaction
Braze acquisition of North Star
We are advising Braze on the transaction